Joel Greenblatt's position in TG Therapeutics is currently worth $1.34 Million. That's 0.02% of their equity portfolio (703rd largest holding). The first TG Therapeutics trade was made in Q3 2019. Since then Joel Greenblatt bought shares five more times and sold shares on six occasions. The stake costed the investor $872 Thousand, netting the investor a gain of 54% so far.